Related Experiment Videos
No improvement of posttraumatic stress disorder symptoms with guanfacine treatment
Thomas C Neylan1, Maryann Lenoci, Kristin W Samuelson
1Department of Psychiatry, University of California, San Francisco, USA. neylan@itsa.ucsf.edu
The American Journal of Psychiatry
|December 8, 2006
Abstract
Objective:
The authors report an 8-week, double-blind, randomized controlled trial of guanfacine versus placebo for posttraumatic stress disorder (PTSD).
Method:
Veterans with chronic PTSD who were medication-free or receiving stable pharmacotherapy were randomly assigned to guanfacine (N=29) versus placebo (N=34).
Results:
Guanfacine had no effect on PTSD symptoms, subjective sleep quality, or general mood disturbances. Guanfacine was associated with a number of side effects.
Conclusions:
These results do not support the use of alpha 2 agonists in veterans with chronic PTSD.